1. 1. Volberding, P. A., & Levine, A. M. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clinical Infectious Diseases;2014, 59(3), 320-327.
2. 2. Takahashi, H., Matsuda, J., & Kusano, Y. HIV-associated anemia: epidemiology and pathogenesis. International Journal of Hematology;2019, 110(3), 287-293.
3. 3. Moyle, G. Mechanisms of HIV and nucleoside reverse transcriptase inhibitor injury to mitochondria. Antiviral Therapy;2010, 15(Suppl 2), 25-38.
4. 4. Mocroft, A., et al.Anemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. AIDS;2019, 33(2), 395-403.
5. 5. Voronin, Y., et al. Immune markers associated with host susceptibility to infection with Mycobacterium avium subspecies paratuberculosis in the HIV-infected host. Immunological Investigations;2018,47(6), 546-560.